AAVantgarde Bio is an Italy-based biotechnology company that researches and develops AAV gene therapies for the treatment of genetic disorders... Read more
AAVantgarde Bio is an Italy-based biotechnology company that researches and develops AAV gene therapies for the treatment of genetic disorders... Read more
News
Jun 08, 2023
Born2Invest
Aavantgarde: AAvantgarde Bio Raises 61 Million - Altas Venture and Forbion Lead the Round
Jun 06, 2023
FinSMEs
Aavantgarde: AAVantgarde Bio Closes 61M Series A Financing
Jun 06, 2023
BioPharma Dive
Aavantgarde: Using twin viruses, startup AAVantgarde aims to extend gene therapy's reach
Sep 09, 2022
BioCentury
Aavantgarde: Misciattelli becomes CEO of Aavantgarde
Sep 08, 2022
FinanzNachrichten
Aavantgarde: Sofinnova Partners: AAVantgarde Bio Appoints Dr. Natalia Misciattelli as Chief Executive Officer
Jun 30, 2022
FirstWord Pharma
Aavantgarde: AAVantgarde Appoints Naveed Shams as Chief Development and Medical Officer
Jun 30, 2022
FinanzNachrichten
Aavantgarde: Sofinnova Partners: AAVantgarde Announces the Appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer
Jun 30, 2021
BioSpace
Aavantgarde: Sofinnova Partners Announces Three New Investments From Its Fund Dedicated to Italian Scientific Research
